APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pulmonary Function Testing Systems

Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.

The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.

Selected research

Market Structure

Global Pulmonary Function Testing Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025194 pages

Choose your research edition.

Industry ResearchPulmonary Function Testing Systems Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Pulmonary Function Testing Systems Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Pulmonary Function Testing Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pulmonary Function Testing Systems Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pulmonary Function Testing Systems Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.

The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.

Global Pulmonary Function Testing Systems main players are CareFusion(BD), Schiller, MGC Diagnostics, M&B, etc. Global top five manufacturers hold a share about 50%. Europe is the largest market, with a share about 30.

Read the full market overview

This report provides an overview of the global Pulmonary Function Testing Systems market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pulmonary Function Testing Systems and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pulmonary Function Testing Systems sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pulmonary Function Testing Systems market size, projected growth trends, production technologies, key applications, and end-use industries.

Pulmonary Function Testing Systems Segment by Company

CareFusion(BD)

Schiller

CHEST

COSMED

nSpire Health

NDD

MGC Diagnostics

Minato

Ganshorn

AESRI

Morgan Scientific

M&B

Sikeda

RSDQ

Pulmonary Function Testing Systems Segment by Type

Portable PFT Systems

Complete PFT Systems

Pulmonary Function Testing Systems Segment by Application

Hospitals

Physical Examination Center

Physician Groups

Others

Pulmonary Function Testing Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Function Testing Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Function Testing Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Function Testing Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pulmonary Function Testing Systems market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pulmonary Function Testing Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pulmonary Function Testing Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pulmonary Function Testing Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pulmonary Function Testing Systems Industry Trends Table 2. Pulmonary Function Testing Systems Industry Drivers Table 3. Pulmonary Function Testing Systems Industry Opportunities and Challenges Table 4. Pulmonary Function Testing Systems Industry Restraints Table 5. Global Pulmonary Function Testing Systems Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pulmonary Function Testing Systems Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pulmonary Function Testing Systems Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pulmonary Function Testing Systems Sales Market Share by Manufacturers Table 9. Global Pulmonary Function Testing Systems Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Pulmonary Function Testing Systems Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pulmonary Function Testing Systems Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pulmonary Function Testing Systems Manufacturers, Product Type & Application Table 13. Global Pulmonary Function Testing Systems Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pulmonary Function Testing Systems by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Portable PFT Systems Table 17. Major Manufacturers of Complete PFT Systems Table 18. Global Pulmonary Function Testing Systems Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Pulmonary Function Testing Systems Sales by Type (2021-2026) & (K Units) Table 20. Global Pulmonary Function Testing Systems Sales by Type (2027-2032) & (K Units) Table 21. Global Pulmonary Function Testing Systems Sales Market Share by Type (2021-2026) Table 22. Global Pulmonary Function Testing Systems Sales Market Share by Type (2027-2032) Table 23. Global Pulmonary Function Testing Systems Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Pulmonary Function Testing Systems Revenue by Type (2021-2026) & (K Units) Table 25. Global Pulmonary Function Testing Systems Revenue by Type (2027-2032) & (K Units) Table 26. Global Pulmonary Function Testing Systems Revenue Market Share by Type (2021-2026) Table 27. Global Pulmonary Function Testing Systems Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals Table 29. Major Manufacturers of Physical Examination Center Table 30. Major Manufacturers of Physician Groups Table 31. Major Manufacturers of Others Table 32. Global Pulmonary Function Testing Systems Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Pulmonary Function Testing Systems Sales by Application (2021-2026) & (K Units) Table 34. Global Pulmonary Function Testing Systems Sales by Application (2027-2032) & (K Units) Table 35. Global Pulmonary Function Testing Systems Sales Market Share by Application (2021-2026) Table 36. Global Pulmonary Function Testing Systems Sales Market Share by Application (2027-2032) Table 37. Global Pulmonary Function Testing Systems Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Pulmonary Function Testing Systems Revenue by Application (2021-2026) & (K Units) Table 39. Global Pulmonary Function Testing Systems Revenue by Application (2027-2032) & (K Units) Table 40. Global Pulmonary Function Testing Systems Revenue Market Share by Application (2021-2026) Table 41. Global Pulmonary Function Testing Systems Revenue Market Share by Application (2027-2032) Table 42. Global Pulmonary Function Testing Systems Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Pulmonary Function Testing Systems Sales by Region (2021-2026) & (K Units) Table 44. Global Pulmonary Function Testing Systems Sales Market Share by Region (2021-2026) Table 45. Global Pulmonary Function Testing Systems Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Pulmonary Function Testing Systems Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pulmonary Function Testing Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Pulmonary Function Testing Systems Sales by Country (2021-2026) & (K Units) Table 49. North America Pulmonary Function Testing Systems Sales by Country (2027-2032) & (K Units) Table 50. Europe Pulmonary Function Testing Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Pulmonary Function Testing Systems Sales by Country (2021-2026) & (K Units) Table 52. Europe Pulmonary Function Testing Systems Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Pulmonary Function Testing Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Pulmonary Function Testing Systems Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Pulmonary Function Testing Systems Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Pulmonary Function Testing Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Pulmonary Function Testing Systems Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Pulmonary Function Testing Systems Sales by Country (2027-2032) & (K Units) Table 59. Global Pulmonary Function Testing Systems Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pulmonary Function Testing Systems Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pulmonary Function Testing Systems Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pulmonary Function Testing Systems Revenue Market Share by Region (2021-2026) Table 63. Global Pulmonary Function Testing Systems Revenue Market Share by Region (2027-2032) Table 64. CareFusion(BD) Company Information Table 65. CareFusion(BD) Business Overview Table 66. CareFusion(BD) Pulmonary Function Testing Systems Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. CareFusion(BD) Pulmonary Function Testing Systems Product Portfolio Table 68. CareFusion(BD) Recent Development Table 69. Schiller Company Information Table 70. Schiller Business Overview Table 71. Schiller Pulmonary Function Testing Systems Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Schiller Pulmonary Function Testing Systems Product Portfolio Table 73. Schiller Recent Development Table 74. CHEST Company Information Table 75. CHEST Business Overview Table 76. CHEST Pulmonary Function Testing Systems Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. CHEST Pulmonary Function Testing Systems Product Portfolio Table 78. CHEST Recent Development Table 79. COSMED Company Information Table 80. COSMED Business Overview Table 81. COSMED Pulmonary Function Testing Systems Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. COSMED Pulmonary Function Testing Systems Product Portfolio Table 83. COSMED Recent Development Table 84. nSpire Health Company Information Table 85. nSpire Health Business Overview Table 86. nSpire Health Pulmonary Function Testing Systems Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. nSpire Health Pulmonary Function Testing Systems Product Portfolio Table 88. nSpire Health Recent Development Table 89. NDD Company Information Table 90. NDD Business Overview Table 91. NDD Pulmonary Function Testing Systems Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. NDD Pulmonary Function Testing Systems Product Portfolio Table 93. NDD Recent Development Table 94. MGC Diagnostics Company Information Table 95. MGC Diagnostics Business Overview Table 96. MGC Diagnostics Pulmonary Function Testing Systems Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. MGC Diagnostics Pulmonary Function Testing Systems Product Portfolio Table 98. MGC Diagnostics Recent Development Table 99. Minato Company Information Table 100. Minato Business Overview Table 101. Minato Pulmonary Function Testing Systems Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Minato Pulmonary Function Testing Systems Product Portfolio Table 103. Minato Recent Development Table 104. Ganshorn Company Information Table 105. Ganshorn Business Overview Table 106. Ganshorn Pulmonary Function Testing Systems Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Ganshorn Pulmonary Function Testing Systems Product Portfolio Table 108. Ganshorn Recent Development Table 109. AESRI Company Information Table 110. AESRI Business Overview Table 111. AESRI Pulmonary Function Testing Systems Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. AESRI Pulmonary Function Testing Systems Product Portfolio Table 113. AESRI Recent Development Table 114. Morgan Scientific Company Information Table 115. Morgan Scientific Business Overview Table 116. Morgan Scientific Pulmonary Function Testing Systems Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Morgan Scientific Pulmonary Function Testing Systems Product Portfolio Table 118. Morgan Scientific Recent Development Table 119. M&B Company Information Table 120. M&B Business Overview Table 121. M&B Pulmonary Function Testing Systems Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. M&B Pulmonary Function Testing Systems Product Portfolio Table 123. M&B Recent Development Table 124. Sikeda Company Information Table 125. Sikeda Business Overview Table 126. Sikeda Pulmonary Function Testing Systems Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Sikeda Pulmonary Function Testing Systems Product Portfolio Table 128. Sikeda Recent Development Table 129. RSDQ Company Information Table 130. RSDQ Business Overview Table 131. RSDQ Pulmonary Function Testing Systems Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. RSDQ Pulmonary Function Testing Systems Product Portfolio Table 133. RSDQ Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Pulmonary Function Testing Systems Distributors List Table 137. Pulmonary Function Testing Systems Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Pulmonary Function Testing Systems Product Image Figure 2. Global Pulmonary Function Testing Systems Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pulmonary Function Testing Systems Market Size (2021-2032) & (US$ Million) Figure 4. Global Pulmonary Function Testing Systems Sales (2021-2032) & (K Units) Figure 5. Global Pulmonary Function Testing Systems Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pulmonary Function Testing Systems Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Portable PFT Systems Image Figure 9. Complete PFT Systems Image Figure 10. Global Pulmonary Function Testing Systems Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Pulmonary Function Testing Systems Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Pulmonary Function Testing Systems Sales Market Share by Type (2021-2032) Figure 13. Global Pulmonary Function Testing Systems Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Pulmonary Function Testing Systems Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pulmonary Function Testing Systems Revenue Market Share by Type (2021-2032) Figure 16. Hospitals Image Figure 17. Physical Examination Center Image Figure 18. Physician Groups Image Figure 19. Others Image Figure 20. Global Pulmonary Function Testing Systems Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Pulmonary Function Testing Systems Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pulmonary Function Testing Systems Sales Market Share by Application (2021-2032) Figure 23. Global Pulmonary Function Testing Systems Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Pulmonary Function Testing Systems Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pulmonary Function Testing Systems Revenue Market Share by Application (2021-2032) Figure 26. North America Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Pulmonary Function Testing Systems Sales Market Share by Country (2021-2032) Figure 28. U.S. Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Pulmonary Function Testing Systems Sales Market Share by Country (2021-2032) Figure 33. Germany Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Pulmonary Function Testing Systems Sales Market Share by Country (2021-2032) Figure 40. China Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Pulmonary Function Testing Systems Sales Market Share by Country (2021-2032) Figure 48. Brazil Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Pulmonary Function Testing Systems Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Pulmonary Function Testing Systems Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pulmonary Function Testing Systems Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pulmonary Function Testing Systems Revenue (2021-2032) & (US$ Million) Figure 59. North America Pulmonary Function Testing Systems Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pulmonary Function Testing Systems Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pulmonary Function Testing Systems Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pulmonary Function Testing Systems Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pulmonary Function Testing Systems Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pulmonary Function Testing Systems Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pulmonary Function Testing Systems Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pulmonary Function Testing Systems Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pulmonary Function Testing Systems Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Portable PFT Systems
  • Complete PFT Systems
Applications
  • Hospitals
  • Physical Examination Center
  • Physician Groups
  • Others
Companies covered
  • CareFusion(BD)
  • Schiller
  • CHEST
  • COSMED
  • nSpire Health
  • NDD
  • MGC Diagnostics
  • Minato
  • Ganshorn
  • AESRI
  • Morgan Scientific
  • M&B
  • Sikeda
  • RSDQ

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pulmonary Function Testing Systems Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pulmonary Function Testing Systems Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pulmonary Function Testing Systems Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pulmonary Function Testing Systems Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pulmonary Function Testing Systems Market Dynamics
  1. 2.1 Pulmonary Function Testing Systems Industry Trends
  2. 2.2 Pulmonary Function Testing Systems Industry Drivers
  3. 2.3 Pulmonary Function Testing Systems Industry Opportunities and Challenges
  4. 2.4 Pulmonary Function Testing Systems Industry Restraints
3 Pulmonary Function Testing Systems Market by Manufacturers
  1. 3.1 Global Pulmonary Function Testing Systems Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pulmonary Function Testing Systems Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pulmonary Function Testing Systems Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pulmonary Function Testing Systems Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pulmonary Function Testing Systems Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pulmonary Function Testing Systems Manufacturers, Product Type & Application
  7. 3.7 Global Pulmonary Function Testing Systems Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pulmonary Function Testing Systems Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pulmonary Function Testing Systems Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pulmonary Function Testing Systems Tier 1, Tier 2, and Tier 3
4 Pulmonary Function Testing Systems Market by Type
  1. 4.1 Pulmonary Function Testing Systems Type Introduction
  2. 4.1.1 Portable PFT Systems
  3. 4.1.2 Complete PFT Systems
  4. 4.2 Global Pulmonary Function Testing Systems Sales by Type
  5. 4.2.1 Global Pulmonary Function Testing Systems Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pulmonary Function Testing Systems Sales by Type (2021-2032)
  7. 4.2.3 Global Pulmonary Function Testing Systems Sales Market Share by Type (2021-2032)
  8. 4.3 Global Pulmonary Function Testing Systems Revenue by Type
  9. 4.3.1 Global Pulmonary Function Testing Systems Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pulmonary Function Testing Systems Revenue by Type (2021-2032)
  11. 4.3.3 Global Pulmonary Function Testing Systems Revenue Market Share by Type (2021-2032)
5 Pulmonary Function Testing Systems Market by Application
  1. 5.1 Pulmonary Function Testing Systems Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Physical Examination Center
  4. 5.1.3 Physician Groups
  5. 5.1.4 Others
  6. 5.2 Global Pulmonary Function Testing Systems Sales by Application
  7. 5.2.1 Global Pulmonary Function Testing Systems Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pulmonary Function Testing Systems Sales by Application (2021-2032)
  9. 5.2.3 Global Pulmonary Function Testing Systems Sales Market Share by Application (2021-2032)
  10. 5.3 Global Pulmonary Function Testing Systems Revenue by Application
  11. 5.3.1 Global Pulmonary Function Testing Systems Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pulmonary Function Testing Systems Revenue by Application (2021-2032)
  13. 5.3.3 Global Pulmonary Function Testing Systems Revenue Market Share by Application (2021-2032)
6 Global Pulmonary Function Testing Systems Sales by Region
  1. 6.1 Global Pulmonary Function Testing Systems Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pulmonary Function Testing Systems Sales by Region (2021-2032)
  3. 6.2.1 Global Pulmonary Function Testing Systems Sales by Region (2021-2026)
  4. 6.2.2 Global Pulmonary Function Testing Systems Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pulmonary Function Testing Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pulmonary Function Testing Systems Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pulmonary Function Testing Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pulmonary Function Testing Systems Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pulmonary Function Testing Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pulmonary Function Testing Systems Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pulmonary Function Testing Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pulmonary Function Testing Systems Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pulmonary Function Testing Systems Revenue by Region
  1. 7.1 Global Pulmonary Function Testing Systems Revenue by Region
  2. 7.1.1 Global Pulmonary Function Testing Systems Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pulmonary Function Testing Systems Revenue by Region (2021-2026)
  4. 7.1.3 Global Pulmonary Function Testing Systems Revenue by Region (2027-2032)
  5. 7.1.4 Global Pulmonary Function Testing Systems Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pulmonary Function Testing Systems Revenue (2021-2032)
  8. 7.2.2 North America Pulmonary Function Testing Systems Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pulmonary Function Testing Systems Revenue (2021-2032)
  11. 7.3.2 Europe Pulmonary Function Testing Systems Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pulmonary Function Testing Systems Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pulmonary Function Testing Systems Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pulmonary Function Testing Systems Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pulmonary Function Testing Systems Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CareFusion(BD)
  2. 8.1.1 CareFusion(BD) Company Information
  3. 8.1.2 CareFusion(BD) Business Overview
  4. 8.1.3 CareFusion(BD) Pulmonary Function Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CareFusion(BD) Pulmonary Function Testing Systems Product Portfolio
  6. 8.1.5 CareFusion(BD) Recent Developments
  7. 8.2 Schiller
  8. 8.2.1 Schiller Company Information
  9. 8.2.2 Schiller Business Overview
  10. 8.2.3 Schiller Pulmonary Function Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Schiller Pulmonary Function Testing Systems Product Portfolio
  12. 8.2.5 Schiller Recent Developments
  13. 8.3 CHEST
  14. 8.3.1 CHEST Company Information
  15. 8.3.2 CHEST Business Overview
  16. 8.3.3 CHEST Pulmonary Function Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CHEST Pulmonary Function Testing Systems Product Portfolio
  18. 8.3.5 CHEST Recent Developments
  19. 8.4 COSMED
  20. 8.4.1 COSMED Company Information
  21. 8.4.2 COSMED Business Overview
  22. 8.4.3 COSMED Pulmonary Function Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 COSMED Pulmonary Function Testing Systems Product Portfolio
  24. 8.4.5 COSMED Recent Developments
  25. 8.5 nSpire Health
  26. 8.5.1 nSpire Health Company Information
  27. 8.5.2 nSpire Health Business Overview
  28. 8.5.3 nSpire Health Pulmonary Function Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 nSpire Health Pulmonary Function Testing Systems Product Portfolio
  30. 8.5.5 nSpire Health Recent Developments
  31. 8.6 NDD
  32. 8.6.1 NDD Company Information
  33. 8.6.2 NDD Business Overview
  34. 8.6.3 NDD Pulmonary Function Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NDD Pulmonary Function Testing Systems Product Portfolio
  36. 8.6.5 NDD Recent Developments
  37. 8.7 MGC Diagnostics
  38. 8.7.1 MGC Diagnostics Company Information
  39. 8.7.2 MGC Diagnostics Business Overview
  40. 8.7.3 MGC Diagnostics Pulmonary Function Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MGC Diagnostics Pulmonary Function Testing Systems Product Portfolio
  42. 8.7.5 MGC Diagnostics Recent Developments
  43. 8.8 Minato
  44. 8.8.1 Minato Company Information
  45. 8.8.2 Minato Business Overview
  46. 8.8.3 Minato Pulmonary Function Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Minato Pulmonary Function Testing Systems Product Portfolio
  48. 8.8.5 Minato Recent Developments
  49. 8.9 Ganshorn
  50. 8.9.1 Ganshorn Company Information
  51. 8.9.2 Ganshorn Business Overview
  52. 8.9.3 Ganshorn Pulmonary Function Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ganshorn Pulmonary Function Testing Systems Product Portfolio
  54. 8.9.5 Ganshorn Recent Developments
  55. 8.10 AESRI
  56. 8.10.1 AESRI Company Information
  57. 8.10.2 AESRI Business Overview
  58. 8.10.3 AESRI Pulmonary Function Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AESRI Pulmonary Function Testing Systems Product Portfolio
  60. 8.10.5 AESRI Recent Developments
  61. 8.11 Morgan Scientific
  62. 8.11.1 Morgan Scientific Company Information
  63. 8.11.2 Morgan Scientific Business Overview
  64. 8.11.3 Morgan Scientific Pulmonary Function Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Morgan Scientific Pulmonary Function Testing Systems Product Portfolio
  66. 8.11.5 Morgan Scientific Recent Developments
  67. 8.12 M&B
  68. 8.12.1 M&B Company Information
  69. 8.12.2 M&B Business Overview
  70. 8.12.3 M&B Pulmonary Function Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 M&B Pulmonary Function Testing Systems Product Portfolio
  72. 8.12.5 M&B Recent Developments
  73. 8.13 Sikeda
  74. 8.13.1 Sikeda Company Information
  75. 8.13.2 Sikeda Business Overview
  76. 8.13.3 Sikeda Pulmonary Function Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sikeda Pulmonary Function Testing Systems Product Portfolio
  78. 8.13.5 Sikeda Recent Developments
  79. 8.14 RSDQ
  80. 8.14.1 RSDQ Company Information
  81. 8.14.2 RSDQ Business Overview
  82. 8.14.3 RSDQ Pulmonary Function Testing Systems Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 RSDQ Pulmonary Function Testing Systems Product Portfolio
  84. 8.14.5 RSDQ Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pulmonary Function Testing Systems Value Chain Analysis
  2. 9.1.1 Pulmonary Function Testing Systems Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pulmonary Function Testing Systems Production Mode & Process
  6. 9.2 Pulmonary Function Testing Systems Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pulmonary Function Testing Systems Distributors
  9. 9.2.3 Pulmonary Function Testing Systems Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst